Purchase Order W81XWH14P0358
Award Date 7/21/14
Potential Completion Date 10/31/15
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95129, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a Cost Plus Fixed Fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The contract, with a ceiling value of $74,513,740.28, is for Clinical Research Organization (CRO) assistance in support of the ACTIV-1 Master Protocol, a clinical trial initiative. The contract is a Delivery Order under the Medical...
- The Food and Drug Administration awarded a BPA call contract valued at $2.07M to Research Triangle Institute (RTI International) for the ALS Functional Ratings Scale-Revised Clinical Outcome Assessment Remote-Use Equivalency Study. Conducted on a time and materials basis, this research initiative is being performed at RTI's headquarters in Research Triangle Park, North Carolina. The study examines the equivalency of remote-use administration for the ALS Functional Ratings Scale-Revised, a...
- Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a firm fixed price call under its existing Blanket Purchase Agreement (BPA) with the National Center for Advancing Translational Sciences (NCATS) on May 20, 2015. The contract, valued at $13,204, is for the provision of recombinant human ubiquitin rhodamine 110 conjugate in a custom size of four 1-milligram units. This award was made without a set-aside designation,...
- This federal contract award is for CLINICAL SITE MONITORING IN HUMAN SUBJECTS FOR AN EXTRAMURAL STUDY TO ASSESS DERMAL PHARMACOKINETIC (PK) AND SYSTEMIC PK UNDER MAXIMUM EXPOSURE CONDITIONS OF LIDOCAINE/PRILOCAINE CREAM TO EVALUATE THE DERMAL-SYSTEMIC CROSSTALK at Joanneum Research, G. The prime contractor is The Emmes Company LLC, a global clinical research organization that provides a wide range of services to support clinical trials and research programs for federal agencies, particularly the...
- The National Institute of Child Health and Human Development (NICHD) awarded a delivery order valued at $2.36 million to Health Decisions, Inc. on August 1, 2025, to serve as the Statistical and Clinical Coordinating Center for the Phase IIB clinical trial of subcutaneous levonorgestrel butanoate, a female contraceptive method under development. The contract, structured as a cost-plus-fixed-fee arrangement, is set aside for small businesses and extends through December 31, 2028. Health...
- This contract award to Research And Diagnostic Systems, Inc. (R&D Systems), a division of Bio-Techne Corporation, is for the provision of recombinant human proteins COMT, PNMT, and Ub-AML. The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded this $35,018 firm-fixed-price purchase order under a total small business set-aside. The requested proteins are essential for target class profiling of methyltransferases, assay development, and other...
- This is a delivery order awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to prime contractor Rho Federal Systems Division Inc. for the Medical Countermeasures Clinical Studies Network. The $12,031,344.00 cost-plus-fixed-fee contract supports clinical studies, including vaccine trials and research network coordination. Major subcontractors include Battelle Memorial Institute for immunogenicity laboratory services,...
- This is a $1,130,545.46 firm fixed-price contract awarded by the Food and Drug Administration (FDA) to Icon Clinical Research LLC, a global provider of outsourced clinical development services. The contract is titled "Evaluation of the Measurement Properties of Patient-Reported Outcome (PRO) Instruments in Patients with Community-Acquired Bacterial Pneumonia (CABP), Hospital-Acquired Bacterial Pneumonia (HABP) and Acute Bacterial Skin and Skin Structure Infections (ABSSSI)" and has a...
- This is a Firm Fixed Price contract awarded by the U.S. Department of Health and Human Services Food and Drug Administration (FDA) to Research Triangle Institute (RTI) International, a non-profit research organization. The $526,321.00 contract was awarded on July 16, 2019 under the FDA's Mission Oriented Business Integrated Services (MOBIS) federal contract vehicle, and the work is scheduled for completion on February 3, 2024. The contract is for "Targeted Mechanism of Action Claims in...
- This is a delivery order issued under a $35 million Indefinite Delivery Contract (IDC) between Actuated Medical, Inc. (a woman-owned small business based in Bellefonte, Pennsylvania) and the National Institute on Drug Abuse (NIDA). The contract supports the Blueprint MedTech (BPMT) Initiative, which aims to develop innovative medical technologies for nervous system disorders. This specific delivery order, valued at $81,702, is for research and development services related to biocompatibility...
R & D SUPPORT, BONT CONSORTIUM, CLIN 001
Posted 7/23/14
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Custom Synthesis of Peptide Inhibitors of Botulinum Neurotoxin | W81XWH-14-T-0207 | Department of the Army Medical Command | Award Notice 1/1 | 5/5/14, 8:08 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.6k | 7/23/14 |